DZ3225A1 - Methode et compositions pour le traitement des maladies pulmonaires - Google Patents

Methode et compositions pour le traitement des maladies pulmonaires

Info

Publication number
DZ3225A1
DZ3225A1 DZ003225A DZ003225A DZ3225A1 DZ 3225 A1 DZ3225 A1 DZ 3225A1 DZ 003225 A DZ003225 A DZ 003225A DZ 003225 A DZ003225 A DZ 003225A DZ 3225 A1 DZ3225 A1 DZ 3225A1
Authority
DZ
Algeria
Prior art keywords
compositions
treatment
lung diseases
lung
diseases
Prior art date
Application number
DZ003225A
Other languages
English (en)
French (fr)
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DZ3225A1 publication Critical patent/DZ3225A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ003225A 1999-11-02 2000-11-01 Methode et compositions pour le traitement des maladies pulmonaires DZ3225A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
DZ3225A1 true DZ3225A1 (fr) 2001-05-10

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ003225A DZ3225A1 (fr) 1999-11-02 2000-11-01 Methode et compositions pour le traitement des maladies pulmonaires

Country Status (29)

Country Link
EP (1) EP1225866A4 (pt)
JP (1) JP2003513028A (pt)
KR (1) KR20020057988A (pt)
CN (1) CN1387404A (pt)
AP (1) AP2002002496A0 (pt)
AR (1) AR029189A1 (pt)
AU (1) AU1357501A (pt)
BG (1) BG106748A (pt)
BR (1) BR0015270A (pt)
CA (1) CA2388333A1 (pt)
CO (1) CO5261512A1 (pt)
CZ (1) CZ20021512A3 (pt)
DZ (1) DZ3225A1 (pt)
EA (1) EA200200518A1 (pt)
EC (1) ECSP003747A (pt)
HK (1) HK1049107A1 (pt)
HU (1) HUP0203152A3 (pt)
IL (1) IL149367A0 (pt)
MA (1) MA26841A1 (pt)
MX (1) MXPA02004350A (pt)
NO (1) NO20022057L (pt)
OA (1) OA12076A (pt)
PE (1) PE20011005A1 (pt)
PL (1) PL355261A1 (pt)
SK (1) SK7592002A3 (pt)
TR (1) TR200201211T2 (pt)
TW (1) TWI242431B (pt)
WO (1) WO2001032127A2 (pt)
ZA (1) ZA200203435B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282469T3 (es) 2001-09-19 2007-10-16 Nycomed Gmbh Combinacion de un nsaid y un inhibidor de pde-4.
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. 医薬組成物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
CA2626628A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CN104338219B (zh) 2010-01-05 2017-10-24 微剂量治疗技术公司 吸入设备和方法
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433997T2 (de) * 1993-06-18 2005-01-27 Smithkline Beecham Corp. Verfahren zur Identifizierung eines PDE IV Hemmers
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
HK1049107A1 (zh) 2003-05-02
WO2001032127A3 (en) 2001-12-06
MXPA02004350A (es) 2002-11-07
TWI242431B (en) 2005-11-01
AU1357501A (en) 2001-05-14
HUP0203152A3 (en) 2004-06-28
CA2388333A1 (en) 2001-05-10
JP2003513028A (ja) 2003-04-08
SK7592002A3 (en) 2002-11-06
EP1225866A4 (en) 2004-04-21
NO20022057L (no) 2002-06-27
ECSP003747A (es) 2002-05-23
NO20022057D0 (no) 2002-04-30
BR0015270A (pt) 2002-06-18
PE20011005A1 (es) 2001-09-28
PL355261A1 (en) 2004-04-05
MA26841A1 (fr) 2004-12-20
WO2001032127A2 (en) 2001-05-10
CN1387404A (zh) 2002-12-25
CZ20021512A3 (cs) 2003-04-16
ZA200203435B (en) 2003-06-25
IL149367A0 (en) 2002-11-10
KR20020057988A (ko) 2002-07-12
EA200200518A1 (ru) 2002-10-31
TR200201211T2 (tr) 2002-08-21
AP2002002496A0 (en) 2002-06-30
OA12076A (en) 2006-05-04
AR029189A1 (es) 2003-06-18
HUP0203152A2 (hu) 2003-01-28
EP1225866A2 (en) 2002-07-31
CO5261512A1 (es) 2003-03-31
BG106748A (en) 2003-02-28

Similar Documents

Publication Publication Date Title
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
FR13C0060I2 (fr) Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
MA26992A1 (fr) Derives de phenethanolamine pour le traitement des maladies respiratoires
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
FIU20060389U0 (fi) Luusairauksien hoito
MA27027A1 (fr) Inhibiteur de pde4 et agent anticholinergique en association pour le traitement de maladies obstructives des voies aeriennes
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE60224163D1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
EP1560593A4 (en) NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES
DE60027290D1 (de) Skleraprothese zur behandlung der weitsichtigkeit und anderer augenkrankheiten
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
HUP0401392A3 (en) Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
EP1425027A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF WOUNDS AND BURNS
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires